ACELLULAR TISSUE ENGINEERED VESSEL
ACELLULAR TISSUE ENGINEERED VESSEL is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Symvess. Available dosage form: implant.
Drug Details
- Generic Name
- ACELLULAR TISSUE ENGINEERED VESSEL
- Brand Names
- Symvess
- Application Number
- BLA125812
- Sponsor
- Humacyte Global, Inc.
- NDC Codes
- 1
- Dosage Forms
- IMPLANT
- Routes
- INTRAVASCULAR
- Active Ingredients
- ACELLULAR TISSUE ENGINEERED VESSEL
Indications and Usage
1 INDICATIONS AND USAGE SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. ( 1 )